semaglutide doping Are GLP-1s Performance-Enhancing Drugs? Studies show Semaglutide (Ozempic, Wegovy,

Acid reflux is a common condition characterized by the backflow of stomach acid into the esophagus

Once approved, prescriptions are processed and treatment begins with ongoing medical supervision

Tirzepatide: GLP-1 and GIP receptor activation Glucose-dependent insulinotropic polypeptide was historically called gastric inhibitory polypeptide

Even people who achieve the treatment goals with the new obesity pharmacotherapies might decide to undergo bariatric surgery to support long-term weight maintenance because either they experience weight regain on the medication or they do not have long-term access to obesity pharmacotherapy, or they prefer not to take obesity pharmacotherapy lifelong

Both agents affect appetite signaling and metabolic pathways, raising concerns about additive effects and unpredictable outcomes